Attendee Highlights
Prior Attending Companies
Please note, the following list is a sample of the 550+ unique organizations we are proud to welcome to our conference each year.
- 5AM Ventures
- Abbvie
- AbbVie Ventures
- Abingworth
- Alexandria Venture Investments
- Ally Bridge Group
- Amgen
- Arch Ventures
- Asahi Kasei Pharma
- Astellas Research Institute of America
- Avalon BioVentures
- Avego
- Avidity Partners
- Bayer
- Biogen
- Boehringer Ingelheim Pharmaceuticals
- Boxer Capital
- Bristol-Myers Squibb
- Canaan
- Cantor Ftizgerald
- Cedars-Sinai Medical Center
- Cystic Fibrosis Foundation
- Daiichi Sankyo
- DAYLI Partners
- Dimension
- Dong-A ST
- EcoR1 Capital
- Eli Lilly and Company
- Flagship Pioneering
- Frazier Life Sciences
- Gilead Sciences
- Goldman Sachs
- HealthCare Royalty (HCRx)
- Illumina Ventures
- insitro
- Johnson & Johnson Innovation
- JP Morgan Chase
- Lilly Ventures
- LYZZ Capital Advisors
- Merck
- Morgan Stanley
- MPM Capital
- National Cancer Institute
- National Institutes of Health Sciences
- Novartis
- Novo Nordisk
- Novo Ventures
- OrbiMed Advisors
- Parker Institute for Cancer Immunotherapy
- Patient Square Capital
- Pfizer
- Pivotal BioVenture Partners
- Playground Global
- Polaris Partners
- RBC Capital Markets
- Red Tree Venture Capital
- RiverVest Venture Partners
- Roche Venture Fund
- Sanford Burnham Prebys Medical Discovery Institute
- Sanford Laboratories for Innovative Medicines
- Sanofi Ventures
- Scripps Research Institute
- SPARK at Stanford
- SR One Capital Management
- SV Health Investors
- The Lundquist Institute
- Third Rock Ventures
- Time BioVentures
- TPG Life Sciences Innovations
- Two Bear Capital
- UCSD Moore’s Cancer Center
- venBio Partners
- Venrock
- Versant Ventures
- Vida Ventures
- Vivo Capital
- Westlake Village BioPartners
- Xaira Therapeutics